WHALEN, COMMISSIONER OF HEALTH OF NEW YORK v. ROE Et Al.
Headline: Denial of stay keeps New York from collecting patient names for certain controlled-drug prescriptions, upholding a lower-court injunction that protects privacy while the appeal proceeds.
Holding: Justice Marshall denied New York’s emergency request, leaving in place the district court’s injunction that bars the State from enforcing mandatory reporting of patients’ names and addresses for Schedule II prescriptions while appeals continue.
- Prevents New York from collecting patient names for Schedule II prescriptions during appeal.
- Protects patient anonymity in the State’s prescription‑monitoring database for now.
- Delays full implementation of New York’s prescription‑tracking computer system.
Summary
Background
The dispute is between the New York Commissioner of Health and a group of doctors, medical organizations, and patients. New York law required doctors to use a triplicate prescription form for Schedule II drugs (high abuse potential but accepted medical use, like opiates and amphetamines) and to send a copy with the patient’s name and address to a state computer. Respondents sued soon after the computer program began, saying mandatory name reporting invaded patient privacy and interfered with doctors’ treatment decisions. A three-judge federal court found for the respondents and barred the State from enforcing those reporting rules.
Reasoning
The main question was whether the State’s need for patients’ names outweighed the privacy interest in the doctor‑patient relationship. The district court, relying on earlier privacy decisions, held that patients have a protected privacy interest in their medications and that the State’s benefit was minimal: the computer had located only one suspected “doctor‑shopper” in 15 months while processing over 125,000 prescriptions per month. Justice Marshall, acting alone on the application for an emergency stay, declined to interrupt the district court’s injunction because the State showed no irreparable injury; doctors and pharmacists keep the original forms for five years and the data could be obtained later.
Real world impact
As a result, New York may not collect and centralize patient names and addresses for Schedule II prescriptions while the appeal continues. The ruling preserves patient anonymity from the State database for now, delays the State’s prescription‑monitoring computer program, and leaves the final legal question to be decided on appeal.
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?